Christopher Patusky, Director at UNITED THERAPEUTICS Corp (UTHR), sold 6,740 shares at $110.75 ($746K) on 2019-03-07, disclosed to the SEC on 2019-03-08.
Seasonal sale ($746k) by Director — this insider has traded UTHR in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.75 | 3,370 | $373K | 50.0% |
| 2 | $110.75 | 3,370 | $373K | 50.0% |
| Total | $110.75 avg | 6,740 | $746K | 100% |
| Filing → |
| UTHR | SELL | 2025-12-16 | $496K | — | Filing → |
| UTHR | SELL | 2025-03-20 | $3.0M | — | Filing → |
| UTHR | SELL | 2025-01-13 | $3.3M | — | Filing → |